Bliss GVS Pharma Ltd


BSE: 506197 | NSE: BLISSGVS | ISIN: INE416D01022 
Market Cap: [Rs.Cr.] 330 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Formulations

 Discuss this stock

Board Meet

28-May-13 
Bliss GVS Pharma Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on May 28, 2013, inter alia, to consider the Audited Financial Results of the Company for the year ended March 31, 2013 and dividend, if any. 
13-Feb-13 
Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2013, inter alia to consider, the Un-audited Financial Results for the Quarter ended December 31, 2012 and Dividend if any. Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 13, 2013, inter alia, has declared an Interim Dividend of 30% i.e. Re. 0.30 per equity share for the year 2012-2013. (As Per BSE Announcement Dated on 13.02.2013) 
09-Nov-12 
Quarterly Results 
10-Aug-12 
Quarterly Results Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 10, 2012, inter alia, has approved the following: 1. Ms. Jyoti Asawa Resign as a Company Secretary of the Company. 2. Mr. Amarendra Mohapatra appointed as a Company Secretary and Compliance Officer of the Company. (As Per BSE Announcement Website Dated on 10/08/2012) 
30-May-12 
Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2012, inter alia, to consider the Audited Financial Results of the Company for the year ended March 31, 2012, and dividend, if any. Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, inter alia, has approved the following; - Recommendation of 40% Dividend i.e. Rs. 0.40 per equity share for the year ended March 31, 2012. (As Per BSE Announcement Dated on 30.05.2012) Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has fixed the date of the 27th Annual General Meeting on August 10, 2012 at 10.00 a.m. (AsPer BSE Announcement Website Dated on 31/05/2012) 

AGM

10-Aug-12
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has fixed the date of the 27th Annual General Meeting on August 10, 2012 at 10.00 a.m. Bliss GVS Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 06, 2012 to August 10, 2012 (both days inclusive) for the purpose of Payment of Dividend & 27th Annual General Meeting (AGM) of the Company to be held on August 10, 2012. Bliss GVS Pharma Ltd has informed BSE that the 27th Annual General Meeting (AGM) of the Company was held on August 10, 2012. (As Per BSE Announcement Dated on 10.08.2012) 
29-Jul-11
AGM 29/07/2011 Bliss GVS Pharma Ltd has informed BSE that the members at the 26th Annual General meeting (AGM) of the Company held on July 29, 2011, have; 1. Approved the Audited Accounts & P&L accounts for the year ended March 31, 2011, the Balance Sheet as at that date and the Reports of the Directors and Auditors. 2. Appointed Mr. G. G. Desai as the director of the Company who was liable to retire by rotation. 3. Re-appointed B. K. Khare & Co. as Statutory Auditors of the Company. 4. Approved Declaration of 30% Dividend whose names appear on the Register of Members of the Company as on July 18, 2011. 5. Appointed Mr. Mayank Mehta as Independent Director of the Company. (As Per BSE Announcement Dated on 30.07.2011) 
03-Aug-10
25th Annual General Meeting on August 03, 2010. Bliss GVS Pharma Ltd has informed BSE that the members at the 25th Annual General Meeting (AGM) of the Company held on August 03, 2010, inter alia, have accorded to the following: 1. Approved and adopted Profit and Loss Account for the year ended March 31, 2010, Balance Sheet as at that day and the Reports of Directors and Auditors thereon. 2. Appointed Mr. Gautam R. Ashore who retires by rotation and eligible offers himself for re-appointment 3. Reappointed M/s. B. K. Khare & Co., as auditors of the Company. 4. Declared dividend @ 5o% per share. 5. Appointed Dr. Vibha N. Kamath as Whole time Director of the Company. 6. Re-appointed and revised salary of Mr. S. N. Kamath as Managing Director of the Company; and 7. Re-appointed and revised salary of Miss. Shruti N. Kamath as Whole time Director of the Company. (As Per BSE Announcement Website dated on 03.08.2010) 
22-Aug-09
AGM 22/08/2009 Bliss GVS Pharma Ltd has informed BSE that the members at the 24th Annual General Meeting (AGM) of the Company held on August 22, 2009, inter alia, have accorded the following: 1. Approved the Audited Accounts & P&L accounts for the year ended March 31, 2009, the Balance Sheet as at that date and the Reports of the Directors and Auditors. 2. Confirmed the appointment Mr. Mahendra N Thakkar as the director of the Company who retired by rotation. 3. Re-appointed B. K. Khare & Co., as Auditors of the Company. 4. Approved Declaration of 15% Dividend whose names appear on the Register of Members of the Company as on August 14, 2009. 5. Appointed Mr. Satej M Katekar as Director of the Company. 6. Approved the Borrowing Power of the Company to Rs 500 cr and delegated the power to the Board. (As Per BSE Announcement Website dated on 24.08.2009) 
12-Sep-08
Bliss GVS Pharma Ltd has informed BSE that the 23rd Annual General Meeting on September 12, 2008. Bliss GVS Pharma Ltd has informed BSE that the 23rd Annual General Meeting (AGM) of the members of the Company will be held on September 12, 2008, inter alia, to consider the following: 1. Approval of Bonus in the ratio of 3 shares for every 5 shares held on the record date; and 2. Commission to the Executive and non-executive Directors. (As per BSE Announcemnt Website dated on 06/08/2008) Bliss GVS Pharma Ltd has informed BSE that the members at the 23rd Annual General Meeting (AGM) of the Company held on September 12, 2008 inter alia, have accorded to the following: 1. The members unanimously rejected the 284 resolution against the Chairman and Director Mr. Govind G Desai and authorized the Board to take against action for defamation for mooting the said resolution without any reason or basis by Mr. Anil Kumar Poddar (holding 10 shares of Rs 1/- each. 2. Approved the Audited Accounts & P&L accounts for the year ended March 31, 2008, the Balance Sheet as at that date and the Reports of the Directors and Auditors. 3. Appointed Mr. Govind G Desai as the director of the Company. 4. Appointed B K Khare & Co. as Auditors of the Company. 5. Approved Declaration of 10% Interim Dividend whose names appear on the Register of Members of the Company as on May 15, 2008. 6. Approved Increase of the Authorised Share Capital of the Company is Rs 150,000,000/- (Rupees Fifteen Crore Only) divided into 150,000,000 (Fifteen Crore) Equity Shares of Re 1/- each. 7. Declared Bonus Shares at the ratio of 3:5 i.e. Three equity shares for Five Shares held. 8. Appointed Dr. Vibha Kamath as Director of the Company. 9. Approved payment of Performance Bonus / Commission to Executive / Non-Executive Director. The Board be any hereby authorize to decide the ratio of payment of performance bonus / commission to Executive Director and Non-Executive Directors. 10. Approved Listing of Shares at National Stock Exchange. 11. The members at their meeting delegate the power for allotment of Bonus Shares to Share Transfer Committee. (As per BSE Announcement dated on 12/09/2008) 

EGM

18-Feb-08
The forthcoming EGM will be held on February 18, 2008. Bliss GVS Pharma Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on February 18, 2008, to consider the following: 1. Split of Shares. 2. Amendment to the capital as mentioned in the Memorandum and Articles of Association of the Company. 3. Regularisation ESPS (Employee Stock Purchase Scheme). (As per BSE Announcement Website dated on 24/01/2008) Bliss GVS Pharma Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on February 18, 2008, inter alia, have accorded the following: 1. Approved - Split Of Shares: The Face Value of Rs 10/- each will be sub divided in to face value of Rs 1/_ each. 2. Amendment to the capital as mentioned in the Memorandum and Articles of Association of the Company. 3. Regularisation ESPS (Employee Stock Purchase Scheme). (As per BSE Announcement Website dated on 18/02/2008) 
15-Feb-07
EGM 15/02/2007 Bliss GVS Pharma Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the Company will be held on February 15, 2007, to transact the business as set out in notice of EGM dated January 15, 2007 dispatched to the shareholders of the Company and to consider preferential allotment of shares to promoter of the Company. (As Per BSE Announcement Website Dated on 22/01/2007) Bliss GVS Pharma Ltd has informed BSE that the members at the Extra Ordinary General meeting (EGM) of the Company held on February 15, 2007, inter alia, have transacted the following business: 1. Approved Take Over of GVS Labs for Rs 16 Cr by issue of 2,666,667 equity shares of face value of Rs 10/- each (at a premium of Rs 50/- each) to the proprietor of GVS Labs and Present Managing Director Mr. S N Kamath. The effective date of takeover of GVS Labs is April 01, 2006. 2. Increase of Authorised Share Capital of the Company from Rs 5 Crore to Rs 10 Crore. 3. Alerted the Capital clause as mentioned in the Article of Association of the Company. (As Per BSE Announcement Website Dated on 15/02/2007) 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma 2,298.88 22.73 6.45 5.40 27.3 24.2 0.72
Plethico Pharma. 702.52 61.01 1.28 33.34 -5.5 3.8 1.08
Sharon Bio-Med. 362.16 7.03 1.98 9.58 19.1 14.1 1.85
Bliss GVS Pharma 330.44 5.63 1.57 2.15 28.0 42.7 0.04
Venus Remedies 315.04 5.51 0.81 3.54 17.7 16.9 0.72
Parenteral Drugs 268.27 0.00 1.06 58.93 -16.1 -0.7 0.86
Kappac Pharma 260.99 0.00 10.88 0.00 0.0 0.0 0.06
Syncom Formul. 260.80 74.97 3.12 13.86 4.3 6.7 0.09
Ahlcon Parent(I) 260.64 20.25 4.82 22.59 12.6 17.0 0.59
Amrutanjan Healt 197.68 16.82 1.98 9.89 12.6 16.3 0.23
Arvind Remedies 153.13 3.77 1.13 6.60 15.1 16.1 2.12
Zenotech Lab. 105.87 0.00 2.05 0.00 0.0 0.0 0.08
Combat Drugs 104.68 0.00 18.10 0.00 0.3 0.3 0.07
Caplin Point Lab 97.61 6.28 3.22 1.38 29.3 33.1 0.30
Hester Bios 96.12 11.83 1.60 4.56 14.4 20.6 0.35

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Govind G Desai , Chairman 

Shibroor N Kamath , Managing Director 

Gautam R Ashra , Director 

Vibha N Kamath , Whole-time Director 


Company Head Office / Quarters:
102 Hyde Park Sakivihar Road,
Andheri East,
Mumbai,
Maharashtra-400072
Phone : 91-22-42160000
Fax : 91-22-28563930
E-mail : info@blissgvs.com
Web : http://www.blissgvs.com
Registrars:
Universal Capital Sec. Pvt Ltd
21 Shakil Niwas
Mahakali Caves Road
Andheri (E)
Mumbai - 400 093

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Closing : Just Dial
Economic Events
list Foreign Buying Japan Bonds (Yen)
list Japan Buying Foreign Bonds (Yen)
Results
list Larsen & Toubro | Zee Entertainmen | Thermax